When to Intervene a Symptomatic Carotid Stenosis?

When to Intervene a Symptomatic Carotid Stenosis

Guidelines recommend that carotid endarterectomy be performed within two weeks of stroke in patients with symptomatic carotid stenosis.

 

Because a Swedish registry study showed patients treated within the first days after a transient ischemic attack or stroke are at increased risk of death and perioperatory stroke, this study aims at verifying this risk in another series of patients in Germany.

 

It included 56,336 elective carotid endarterectomies performed in patients with symptomatic stenosis between 2009 and 2014. The overall population was divided in four cohorts according to time interval between index event and surgery.

Cohort 1: 0 to 2 days.

Cohort 2: 3 to 7 days.

Cohort 3: 8 to 14 days.

Cohort 4: 14 to 180 days.

 

Primary end point was stroke or inhospital death. A multilevel multivariable regression model was used for risk adjusted analyzis, given the differences between cohorts.

 

With a mean age of 71.1±9.6 years and 67.5% men, the overall rate of any stroke or death was 2.5% (n=1.434).

 

Risk of any inhospital stroke or death was:

  • 3% for the group intervened within 48 hours of index event
  • 2.5% for the group intervened between days 3 and 7
  • 2.6% for the group intervened between days 7 and 14
  • 2.3% for those intervened between days 14 and 180

 

At multivariable analyzis, the study showed the time of intervention was not significantly associated to events.

 

Even though this study does not assess recurrent events in patients awaiting intervention, but only inhospital events post procedure, we are well aware patients are a high risk of events and, therefore, early intervention is recommended.

 

Historically, early intervention has been resisted by surgeons, because of the supposedly high periprocedural events rate. Mostly, they have tried to “cool the case down”.

 

Conclusion

A shorter time interval between index event and carotid endarterectomy was not associated with an increased risk of peri-procedural events such as death or stroke in patients with symptomatic carotid stenosis.

 

Original Title: Short Time Interval Between Neurologic Event and Carotid Surgery Is Not Associated With an Increased Procedural Risk.

Reference: Pavlos Tsantilas et al. Stroke. 2016 Oct 13. Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....